XNAS · DRIO
-3.05% · -$0.2200 · Vol 2.7K
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
DarioHealth Corp. Common Stock

DarioHealth Corp. Common Stock

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$7.00
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is DRIO moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for DRIO are being assembled.
About DarioHealth Corp. Common Stock
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2013
Employees
165
Country
US

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$6.89
Day high
$7.18
Day low
$6.88
Previous close
$7.22
52W high
$7.35
-4.76% from high
52W low
$6.06
73% of range
Market cap
$52.8M
P/E
1.55×
EPS
$4.53
Shares out
7.3M
Volume
2.7K
VWAP
$7.00
Price history computed in-house
1W
+0.57%
1M
-3.31%
SMA 50 $6.91 · above
SMA 200 $6.91 · above
52W position 73%
Veridion warehouse edge

Warehouse intelligence for DRIO.

Veridion Score
56
0: 891: 612: 523: 104: 785: Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

DRIO insider activity

DarioHealth Corp. Common Stock

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for DRIO.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

DRIO contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for DRIO in this window.
Lobbying spend

DRIO lobbying filings, year to date.

Registered lobbying filings matched to DarioHealth Corp. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for DRIO in this window.
Latest news · DRIO
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for DRIO.
Options
Sovereign unlock shows live options positioning for DRIO.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.